News
Hosted on MSN1mon
It's going to be 'put up or shut up' for Novo Nordisk's Wegovy this summer: Barclays' Emily FieldEmily Field, Barclacys head of European pharmaceuticals equity research, joins 'Squawk Box' to discuss Novo Nordisk's quarterly earnings results, impact of copycat compounded drugs on Wegovy sales ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback